AIM ImmunoTech announced Nancy Bryan as the newest member of its Board of Directors. She has also been named to a number of committees. Bryan is an established leader with more than 25 years of experience in the life sciences industry. She has served on executive leadership teams and played key roles in companies’ successes, including marketing, sales, business development, financing and communications. Bryan is the current President and CEO of BioFlorida.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AIM:
- AIM ImmunoTech Bolsters Board of Directors with Appointment of Pharmaceutical Industry Veteran Nancy K. Bryan, with Deep Commercial, Marketing, Business Development and Corporate Finance Expertise
- Aim Immunotech Inc. (AIM) Q4 Earnings Cheat Sheet
- AIM ImmunoTech to Report Full Year 2022 Financial Results on March 31, 2023 and Host Inaugural Quarterly Conference Call and Webcast
- AIM ImmunoTech Announces Late-Breaking Presentation at the International Conference on Antiviral Research Regarding Ampligen as a Potential Therapy Against Ebola Virus Disease
- AIM ImmunoTech announces presentation on Ampligen in Ebola virus disease
